Global Post‑Surgical Infection and Organ Preservation Markets Projected to Grow by 2035

The post‑surgical infection market was valued at about USD 1.76 billion in 2025 and is forecast to reach roughly USD 2.56 billion by 2035, expanding at a compound annual growth rate of 3.8%. Growth is driven by an increase in surgical procedures, heightened awareness of hospital‑acquired infections, a shift toward minimally invasive and outpatient surgeries, and demand for advanced wound‑care products such as antimicrobial dressings and negative‑pressure therapy. Regulatory initiatives in the United States and the European Union, along with emerging technologies like nanotechnology‑based wound care, are also supporting market expansion.

The organ preservation market stood at approximately USD 300.35 million in 2025 and is expected to grow to about USD 570.18 million by 2035, reflecting a 6.62% CAGR. Demand is fueled by the rising incidence of organ failure, the need for more effective preservation methods in transplantation, and advances such as static cold storage, normothermic perfusion, and digital monitoring solutions. Sustainability concerns and a lack of standardisation in preservation techniques are shaping industry innovation and investment.

Both markets are projected to benefit from continued investment in research and development, evolving clinical practices, and supportive policy environments worldwide.